Evidence map›Paper›PMID 40884223›Full record

ArticleJournal of managed care & specialty pharmacy2025

Cost-related barriers to medication use among diverse participants with obesity-associated asthma.

Luyu Xie, Joohan Kim, Jaime P Almandoz, Folashade Afolabi, Tanya Martinez Fernandez, Andrew Gelfand, Joshua M Liao, Sarah E Messiah

Abstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luyu XiePeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas.
Joohan KimTexas A&M University, College Station.
Jaime P AlmandozDivision of Endocrinology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
Folashade AfolabiDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas.
Tanya Martinez FernandezDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas.
Andrew GelfandDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas.
Joshua M LiaoDivision of General Internal Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
Sarah E MessiahPeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndividuals with obesity-associated asthma (OAA) have worse health outcomes than those with asthma and healthy weight (no OAA). The impact of cost barriers on medication use and how it varies by racial and ethnic groups is unclear.

objectiveTo assess the impact of cost barriers on medication use in OAA across racial and ethnic groups.

methodsThis cross-sectional study included adults with asthma who participated in the All of Us program between May 2017 and August 2024. OAA was defined as having both asthma (confirmed by the electronic health record) and obesity (body mass index [BMI]≥30 kg/m

resultsA total of 21,108 patients (mean age 58.9 years, 73.6% female, 11.9% Hispanic/Latinx, 67.2% non-Hispanic White, 13.0% non-Hispanic Black, 1.5% non-Hispanic Asian, and 6.3% other) were included, with 51.7% having OAA (mean BMI of 38.6 kg/m

conclusionsSignificant disparities exist in cost-related barriers among individuals with OAA from different ethnic backgrounds. This highlights the need for tailored health care interventions that address the specific needs of diverse populations, aiming to reduce health disparities and improve asthma outcomes.

Indexed as

Anti-Asthmatic AgentsAsthmaObesityAdultAgedBody Mass IndexCross-Sectional StudiesEthnicityFemaleHealth Services AccessibilityHumansMaleMiddle AgedUnited StatesAnti-Asthmatic Agents

Identifiers

PMID40884223
PMCPMC12397981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.